OPEN MARKET SALE AGREEMENTSMApogee Therapeutics, Inc. • August 12th, 2024 • Biological products, (no disgnostic substances) • New York
Company FiledAugust 12th, 2024 Industry Jurisdiction
OPEN MARKET SALE AGREEMENTSMInotiv, Inc. • August 9th, 2024 • Services-commercial physical & biological research • New York
Company FiledAugust 9th, 2024 Industry Jurisdiction
OPEN MARKET SALE AGREEMENTSMHOOKIPA Pharma Inc. • August 8th, 2024 • Pharmaceutical preparations • New York
Company FiledAugust 8th, 2024 Industry JurisdictionHOOKIPA Pharma Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.0001 per share (the “Common Shares”), having an aggregate offering price of up to $50,000,000 on the terms set forth in this agreement (this “Agreement”).
OPEN MARKET SALE AGREEMENTSMCorvus Pharmaceuticals, Inc. • August 6th, 2024 • Pharmaceutical preparations • New York
Company FiledAugust 6th, 2024 Industry Jurisdiction